Know the Rules in Your State So You Can Flavor Medications with Confidence.
Pharmacists and pharmacy technicians, we created this site to help you understand the rules around medication flavoring to ensure your policies and procedures follow your State Board of Pharmacy regulations or guidance. Importantly, the information contained here reflects most State Board of Pharmacy rules or guidance passed after the November 2022 publication of new USP 795 non-sterile compounding standards.
If you have any questions, please don’t hesitate to contact us by sending an email to regulatory@flavorx.com
Click the map or follow the links below to see how medication flavoring is treated in your state.
Map Legend
Of note, Illinois says flavoring is not compounding in statute. Both NC BOP & MA BOP guidance says flavoring is compounding but only require documentation, not full USP 795.
85% of children between ages 0-11 live in states that do not subject flavoring to USP 795 standards.
88% of U.S. pharmacies operate in states that do not subject flavoring to USP 795 standards.
250 million medications have been flavored over the past 25 years without a single reported issue of harm.
A: USP establishes guidelines to follow for non-sterile compounding. It’s up to each state to determine whether those guidelines will be enacted or enforced. A few states require compliance with USP standards when flavoring, but most don’t. The consensus amongst State Boards of Pharmacy is that USP 795 standards are excessive when it comes to medication flavoring.
A: Simple. Ask your flavoring supplier for tests showing their flavors do not impact the stability of medications. FLAVORx regularly tests our flavors when added to medications to ensure they are inert. We are happy to share copies of these test with you if you need them. If you work at a chain pharmacy, your corporate office usually has them on file.
A: If your State Board of Pharmacy requires you to document each time you flavor, they will typically ask you to record the date, time, initials of the person flavoring the medications, drug name, and flavors added. Sometimes you’ll be asked to document lot numbers and expiry dates of the flavors. We’re happy to help you navigate documentation requirements specific to your state.
Have questions about your state’s rules or need help interpreting a regulation? We can help!
Email: regulatory@flavorx.com
Phone: 800-884-5771
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
https://drive.google.com/file/d/17QLcEuQm81OlPMBG5D5pmf-RIVkYjQZ-/view
https://www.pharmacy.ca.gov/laws_regs/lawbook.pdf
Note: Flavoring will be regulated as compounding with full adherence to USP 795 standards
“Compounding” does not include reconstitution of a drug pursuant to a manufacturer’s direction(s), nor does it include the sole act of tablet splitting or crushing, capsule opening, or the addition of flavoring agent(s) to enhance palatability.
https://www.sos.state.co.us/CCR/GenerateRulePdf.do?ruleVersionId=9470&fileName=3%20CCR%20719-1
3.00.55 Prescription Flavoring. A flavor additive may be incorporated into a non-sterile prescription under the following conditions: a. The patient, patient’s caregiver, or practitioner who authorized the original prescription shall authorize the flavoring of each new and, if applicable, refilled prescription. b. The flavor additive shall in no way compromise the stability, safety, or efficacy of the dispensed drug. c. No expired flavor additive shall be incorporated into a prescription. No flavor additive shall be incorporated which will expire prior to utilization by the patient, based on the practitioner’s directions for use. d. For flavoring additives that do not have expiration dates assigned by the manufacturer or supplier, a pharmacist shall clearly and legibly label the container with the date of receipt and assign a conservative expiration date, not to exceed three years after receipt, to the flavoring additive. In no event shall the labeled date of receipt or assigned expiration date be later altered after originally labeling the container. e. The following information shall be recorded and maintained in a suitable hard-copy or electronic dispensing record for a period of two years from the date of flavoring the corresponding new or refilled prescription. This record shall be made available, in printed form, for the Board or its representatives immediately upon the request of the Board or its representatives. 1) Additive’s flavor; 2) Flavor additive’s manufacturer 3) Flavor additive’s lot number (if available); and 4) Flavor additive’s expiration date. f. The pharmacist responsible for conducting the final evaluation of a new or refilled prescription shall also be responsible for the flavoring of the prescription as specified in subsections a., b., and c. of this Rule 3.00.55. g. The pharmacist manager shall be responsible for subsection d. of this Rule 3.00.55 and the maintenance of records as specified in subsection e. of this Rule 3.00.55.
https://www.cga.ct.gov/current/pub/chap_400j.htm#sec_20-617a
Sec. 20-617a. Flavoring agent added to prescription product. Exemptions. (a) For purposes of this section, “flavoring agent” means an additive used in food or drugs when such additive (1) is used in accordance with good manufacturing practice principles and in the minimum quantity required to produce its intended effect, (2) consists of one or more ingredients generally recognized as safe in food and drugs, has been previously sanctioned for use in food and drugs by the state or the federal government, meets United States Pharmacopeia standards or is an additive permitted for direct addition to food for human consumption pursuant to 21 CFR 172, (3) is inert and produces no effect other than the instillation or modification of flavor, and (4) is not greater than five per cent of the total weight of the product.
(b) A flavoring agent may be added to a prescription product by (1) a pharmacist upon the request of the prescribing practitioner, patient for whom the prescription is ordered or such patient’s agent, or (2) a pharmacist acting on behalf of a hospital, as defined in section 19a-490.
(c) The addition of a flavoring agent in accordance with subsections (a) and (b) of this section shall be exempt from the requirements established in subsections (a) to (m), inclusive, of section 20-633b, any regulations adopted pursuant to subsection (o) of section 20-633b and United States Pharmacopeia, Chapter 795, Pharmaceutical Compounding – Nonsterile Preparations, and Chapter 800, Hazardous Drugs, as both may be amended from time to time.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
https://regulations.delaware.gov/register/june2024/proposed/27%20DE%20Reg%20955a%2006-01-24.htm
Pursuant to 24 Del.C. §2506(a)(1), the Delaware Board of Pharmacy (“Board”) has proposed revisions to its Rules and Regulations. First, the Board proposes to amend subsection 5.1.6, pertaining to compounding, to state that the definition of “compounding” does not include flavoring of conventionally manufactured medications provided that the flavors used are inert, tested, and do not alter a medication’s concentration beyond USP’s accepted level of variance.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
See Notice of Intent to Adopt as Rule 480-11-.10. Exceptions
TEXT OF PROPOSED GEORGIA STATE BOARD OF PHARMACY RULE- RULE 480-11-.10 EXCEPTIONS
(1) The requirements of this chapter do not apply to the compounding or mixing of FDA approved drugs preparations pursuant to the manufacturer’s directions for dispensing including but not limited to the reconstitution of oral suspensions, combination of the components of topical preparations, etc.
(2) The act of adding flavoring agents to conventionally manufactured drug products, on its own, shall not be considered an act of pharmaceutical compounding.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
https://www.legis.iowa.gov/docs/iac/chapter/657.20.pdf
Compounding does not include the use of a flavoring agent to flavor a drug pursuant to rule 657—20.13(124,126,155A), nor does it include mixing or reconstituting a drug according to the product’s manufacturer label.
“Flavoring agent” means a therapeutically inert, nonallergenic substance consisting of inactive ingredients that is added to a drug to improve the drug’s taste and palatability.
657—20.13(124,126,155A) Use of flavoring agents. A flavoring agent may be added to a drug at the discretion of the pharmacist or upon the request of the prescriber, the patient, or the patient’s agent. The pharmacist may add flavoring agents not to exceed 5 percent of the total volume of the drug to which the flavoring agents are added. The pharmacist shall label the flavored drug with a beyond-use date no greater than 14 days past the date the flavoring agent is added if the drug is required to be stored in a refrigerator. A different beyond-use date or alternate storage conditions may be indicated if such variation is supported by peer-reviewed medical literature. The pharmacist shall electronically or manually document that a flavoring agent was added to a drug, and such documentation shall be made available for inspection and copying upon the request of the board or an agent of the board
https://adminrules.idaho.gov/rules/current/24/243601.pdf
https://www.ilga.gov/legislation/ilcs/ilcs3.asp?ActID=1318&ChapterID=24
(o) “Compounding” means the preparation and mixing of components, excluding flavorings, (1) as the result of a prescriber’s prescription drug order or initiative based on the prescriber-patient-pharmacist relationship in the course of professional practice or (2) for the purpose of, or incident to, research, teaching, or chemical analysis and not for sale or dispensing.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
https://www.pharmacy.ks.gov/forms-faqs/faqs
At their February 22, 2024, meeting, the board confirmed their continued opinion that the addition of flavoring to a commercial oral liquid medication is not compounding if certain conditions are met. Please note the board does not speak for other jurisdictions (FDA, other states, etc.) to which a facility may be subject. The conditions that must be met include:
https://apps.legislature.ky.gov/law/kar/titles/201/002/076/
Section 9. Enforcement Discretion.
(2) The board shall not enforce the USP 795 standard that the addition of flavoring to a commercially available drug is compounding, if the additive:
(a) Is non-expired, inert, nonallergenic, and produces no effect other than the instillation or modification of flavor; and
(b) Is not greater than five (5) percent of the drug product’s total volume.
Louisiana Board of Pharmacy Policies & Procedures
Title: Addition of Flavors to Medications- Policy No. I.A.31
Following their review of the pharmacy law and rule, the Board determined a rule was not necessary and that an enforcement policy statement would be appropriate. The following motion was adopted after a unanimous vote in the affirmative.
Resolved, that the Board adopt an enforcement policy, such that the addition of nonallergenic and inert flavoring agents to commercially available liquid oral products resulting in a change in the final product volume of less than 5% shall not require a prescriber’s order or a full compounding log.
https://www.mass.gov/doc/2023-07-non-sterile-compounding-pdf/download
III. Non-Sterile Compounding Process
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
R 338.501 Definitions.
“Compounding” does not include any of the following:
(iv) Flavoring agents added to conventionally manufactured and commercially available liquid medications. Flavoring agents must be nonallergenic and inert, not exceeding 5% of a drug product’s total volume.
https://mn.gov/boards/pharmacy/resourcesfaqs/faqs/compounding.jsp
Compounding
Yes. United States Pharmacopeia (“USP”) has determined adding a component such as flavoring not stipulated in the labeling to a conventionally manufactured nonsterile product is compounding and has been within the scope of USP <795> since 2004. USP has reemphasized this in its November 1, 2022 guidance document entitled “<795>: Adding Flavor to Conventionally Manufactured Nonsterile Products.”
Additionally, Minnesota Rule 6800.3300, subpart 1 sets forth the standards for nonsterile compounding. The rule states that if pharmacies engage in nonsterile compounding, they must follow USP <795> standards.
The Minnesota Board of Pharmacy (“Board”) recognizes the importance of this service, particularly in the pediatric population. Furthermore, the Board is aware the majority of states, including those states who border with Minnesota and whose resident pharmacies may directly serve Minnesota patients, have either enacted rules or statutes creating exceptions for flavoring, or have indicated they may use enforcement discretion when applying USP <795> standards to its licensees who add flavoring.
Accordingly, at this time, if a licensed Minnesota pharmacy elects to add flavoring to a conventionally manufactured product for the purpose of improving palatability, the Board may exercise its enforcement discretion regarding the applicable USP <795> requirements with the exception of the following USP <795> requirements:
The Board also expects its licensees to follow and adhere to all other applicable state and federal rules and laws while conducting pharmacy operations.
https://pr.mo.gov/boards/pharmacy/practiceguide.pdf
(New Guide expected April 2025)
SECTION H: MEDICATION DISPENSING
H.14 FLAVORING
Licensees may flavor a legend product unless the prescriber indicates otherwise. OTC products may only be flavored by prescription. Licensees should indicate that the product was flavored on the patient’s container and the added flavoring must be documented in the pharmacy’s prescription record (e.g., in a flavoring book or in the prescription record). As defined by the Board’s rules, flavoring does not constitute compounding. Licensees may not flavor a prescription dispensed by another pharmacy.
The Board is aware that USP is reviewing whether flavoring constitutes compounding. The Board has not adopted USP’s proposed revision at this time but may reconsider this approach in the future.
SECTION I: COMPOUNDING
As defined by the Board’s rules, compounding does not include incorporating a flavoring agent. However, licensees should indicate that the product was flavored on the patient container and the added flavoring must be documented in the prescription record. (See section H.14 for additional information on flavoring).
https://www.sos.ms.gov/adminsearch/ACProposed/00027414b.pdf
ARTICLE XXXI COMPOUNDING GUIDELINES
C. For the purpose of this Article, flavoring is not considered compounding. |
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
https://www.ncbop.org/faqs/general-pharmacy-faqs.html
Pharmacy Practice FAQs
Is adding flavoring to a conventionally manufactured product considered compounding?
USP considers adding flavoring to a conventionally manufactured product to fall within the scope of compounding, because there are known instances when flavoring components have destabilized a product. If a pharmacy adds flavoring to a manufactured product it must take into account the manufacturer’s Beyond Use Date (BUD) and the effect on stability caused by adding flavoring. If a flavoring component is added to a manufactured product that does not contain a preservative (e.g., reconstitution of amoxicillin oral suspension) the BUD is 14 days refrigerated or shorter if indicated in the manufacturer’s labeling. If a flavoring component is added to a manufactured product that contains a preservative (e.g., pyridostigmine oral solution), then the BUD is 35 days in controlled room temperature or refrigerated or shorter if indicated in the manufacturer’s labeling. When adding flavoring the compounding record must include the flavor manufacturer or product, lot number, and expiration date. All of this information about the flavoring must be documented in the patient record notes for the prescription.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
https://nebraskalegislature.gov/laws/statutes.php?statute=38-2867.01
(4) Any authorized person splitting a scored tablet along scored lines or adding flavoring to a commercially available drug product is not engaged in compounding.
https://gc.nh.gov/rsa/html/XXX/318/318-mrg.htm
“Compounding” shall not include the reconstitution of powdered formulations before dispensing or the addition of flavoring. “Compounding” shall not include the simple addition of flavoring, nor shall it include the preparation of a single dose of a nonhazardous commercially available drug or licensed biologic for administration within 2 hours of preparation to an individual patient when done in accordance with the manufacturer’s approved labeling or instructions consistent with that labeling.
https://www.njconsumeraffairs.gov/regulations/Chapter-39-State-Board-of-Pharmacy.pdf
c) A compounding record shall not be required for:
2) Product flavoring.
https://www.srca.nm.gov/parts/title16/16.019.0030.html
(4) the addition of a flavoring agent to a conventionally manufactured product is not considered compounding as long as the following conditions are met:
(a) the flavoring agent is inert, nonallergenic, and produces no effect other than the instillation or modification of flavor;
(b) the flavoring agent does not alter a medication’s concentration beyond USP’s accepted level of variance;
(c) the addition of flavoring agent(s) is documented in the prescription record.
Sec. 4.
(a) Make a record contemporaneous with the completion of the mixture, including, without limitation, the ingredients of the oral drug product;
(b) Ensure that the flavor additive does not compromise the stability, safety or efficacy of the dispensed oral drug product; and
(c) Assign the applicable beyond-use date to the oral drug product pursuant to chapter 795 of the United States Pharmacopeia – National Formulary, as adopted by reference in paragraph (b) of subsection 1 of NAC 639.670.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
https://codes.ohio.gov/ohio-administrative-code/rule-4729:7-2-01
A pharmacy engaged in the following shall not be required to comply with the provisions of this chapter:
(4) The addition of a flavoring agent to a conventionally manufactured drug product.
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
https://olis.oregonlegislature.gov/liz/2024R1/Downloads/MeasureDocument/HB4010/A-Engrossed
DRUGS
https://www.pshp.org/news/479128/Information-on-USP.htm
The following decisions were approved by the Board and placed on record:
No BOP rule/guidance in place. However, flavoring does not appear to be subject to USP 795 standards per enforcement discretion.
https://llr.sc.gov/bop/PFORMS/InspectionForms/Non-Sterile%20Compounding%20Pharmacy.pdf
Non-Sterile Compounding Inspection Form
Simple compounding that does not precipitate the application of this form include:
1) Reconstituting or manipulating commercial products that may require the addition of one or more ingredients as directed by the manufacturer;
2) Making twenty or less compounds of an oral liquid or topical dosage form utilizing five or less non-hazardous APIs over any 30 day period (not exempt from 40-43-86(CC)(6), “Formulas and Logs Maintained”).
https://doh.sd.gov/media/grxhx0od/2051_bop_proposed-rules-final-all-black.pdf
20:51:31:38. Non-hazardous, non-sterile drug exclusions. Drug manipulations are excluded from United States Pharmacopeia requirements when: (1) Dispensing nonsterile products with a formulation commercially available, where the packaging details the exact preparation; (2) The addition of a flavoring agent to a drug product as outlined in flavoring manufacturer instructions; and (3) Reconstitution with the addition of distilled or purified water.
|
https://publications.tnsosfiles.com/rules/1140/1140-07.20240314.pdf
1140-07-.09 NONSTERILE SIMPLE COMPOUNDING PREPARATIONS
(2) Solely adding flavoring to medications is not considered compounding.
https://www.pharmacy.texas.gov/files_pdf/TSBP%20Rules_MASTER%20FILE.pdf
(H) A pharmacist may add flavoring to a prescription at the request of a patient, the patient’s agent, or the prescriber. The pharmacist shall label the flavored prescription with a beyond-use-date that shall be no longer than fourteen days if stored in a refrigerator unless otherwise documented. Documentation of beyond-use-dates longer than fourteen days shall be maintained by the pharmacy electronically or manually and made available to agents of the board on request. A pharmacist may not add flavoring to an over-the-counter product at the request of a patient or patient’s agent unless the pharmacist obtains a prescription for the over-the-counter product from the patient’s practitioner.
|
https://adminrules.utah.gov/public/rule/R156-17b/Current%20Rules
(13) “Compounding,” as defined in Subsection 58-17b-102(18), in accordance with 21 U.S.C. 353a(e) Pharmacy Compounding, does not include:
(a) mixing, reconstituting, or other such acts that are performed in accordance with directions in approved labeling provided by the product’s manufacturer and other manufacturer directions consistent with that labeling; or
(b) the addition of flavoring agents to conventionally manufactured and commercially prepared available liquid medications, if the flavoring agents:
(i) are therapeutically inert; and
(ii) do not exceed 5% of a preparation’s total volume.
https://www.dhp.virginia.gov/media/dhpweb/docs/pharmacy/guidance/110-36.pdf
Yes, but the Board will exercise enforcement discretion of USP compounding standards for flavoring.
See Board of Pharmacy Meeting Minutes 6-28-23
This language was approved by the Vermont Board of Pharmacy in 2023 and is entirely new.
Addition of flavoring agents to conventionally manufactured products is not considered compounding; provided that the flavoring agent is inert and does not alter the product’s concentration beyond USP’s accepted level of variance, and that the pharmacy labels the product with an expiration date and storage instructions consistent with any effect on stability caused by the addition of flavoring. The addition of flavoring must be documented as part of the prescription record, reconstitution log, or other similar documentation. The documentation shall include the agent’s flavor, manufacturer, lot number, and expiration date.
|
https://doh.wa.gov/sites/default/files/2024-02/690-318-GeneralSelfInspectionWorksheet.pdf
In Washington State, compounding is defined in RCW 18.64.011(6) and means “the act of combining two or more ingredients in the preparation of a prescription. Reconstitution and mixing of (a) sterile products according to federal food and drug administration approved labeling does not constitute compounding if prepared pursuant to a prescription and administered immediately or in accordance with package labeling, and (b) nonsterile products according to federal food and drug administration-approved labeling does not constitute compounding if prepared pursuant to a prescription.”
Please note: If a pharmacy adds flavoring to a commercially available product, it is considered compounding and the non-sterile compounding self-inspection worksheets must also be completed.
https://dsps.wi.gov/Documents/RulesStatutes/Phar15EIA2.pdf
Phar 15.02 Incorporation of Standards. (1) PHARMACEUTICAL COMPOUNDING – NONSTERILE PREPARATIONS. USP-NF general chapter 795, official as of November 1, 2023, is incorporated by reference into this chapter, subject to the exception that nonsterile compounding does not include the addition of nonallergenic, therapeutically inert flavoring agents to a conventionally manufactured drug product. The pharmacist shall also comply with the following requirements when adding flavoring agents to a drug product: (a) The pharmacist shall ensure that the flavoring agent is not more than 5 percent of the product’s total volume. (b) The pharmacist shall label the flavored prescription with a beyond-use-date that shall be no longer than fourteen days if stored in a refrigerator unless otherwise documented. (c) The pharmacist shall document the addition of flavoring as part of the prescription record. The documentation shall include the type of flavoring agent, manufacturer, lot number, and expiration date. (d) A prescription is required before a pharmacist may add flavoring to an over-the-counter product.
|
https://apps.sos.wv.gov/adlaw/csr/readfile.aspx?DocId=57188&Format= PDF
2.1.7.c. The following are not “compounding” and are exempt from USP 795 Compounding Standards:
2.1.7.c.3. upon the request of the prescribing practitioner and/or the patient for whom the prescription is ordered or such patient’s agent, the addition of therapeutically inert, nonallergenic flavoring agents to a commercially manufactured product, not in excess of five percent (5%) of the preparation’s total volume;
https://rules.wyo.gov/Search.aspx?Agency=059
See Pharmacy Board of (059)- Pharmacy Board of (0001)- General Practice of Pharmacy Regulations Chapter 2
Section 3
(iv) Compounding does not include mixing, reconstituting, adding flavoring or other such acts that are performed in accordance with directions contained in approved labeling provided by the product’s manufacturer and other manufacturer directions consistent with the labeling.
Section 13
(iii) No compounded or flavored prescription may be returned to stock;